SBIR Phase I: Multiplexed suspension array for rapid, point-of-care molecular diagnostics

SBIR 第一阶段：用于快速护理点分子诊断的多重悬浮阵列

• 批准号: 0712045
• 负责人: Daniel Engebretson
• 金额: $ 9.85万
• 依托单位: Prairie Scientific Innovations
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2007-12-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0712045&HistoricalAwards=false
• 关键词: SBIR; Phase; Multiplexed; suspension; array

This Small Business Innovation Research (SBIR) Phase I research project aims to develop a microbead-based suspension array product for molecular diagnostics (genetic screening) that can make multiplexed measurements in near-real-time without the need for sample amplification and fluorescent labeling.The technology could have a direct positive impact on the diagnostic market for both humans and animals and will enable healthcare providers to make more educated assessments of a patient's disease profile and potential responsiveness to different therapeutic modalities.

该小型企业创新研究 (SBIR) 第一阶段研究项目旨在开发一种用于分子诊断（基因筛查）的基于微珠的悬浮阵列产品，该产品可以近乎实时地进行多重测量，而无需样本扩增和荧光标记。该技术可能对人类和动物的诊断市场产生直接的积极影响，并使医疗保健提供者能够对患者的疾病概况和潜力进行更有根据的评估 对不同治疗方式的反应。